Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1992-2025

Fresenius Medical Care Holdings, Inc. recalls 5008X HDF Hemodialysis Blood Tubing Set

Fresenius Medical Care Holdings, Inc.Waltham, MA, United StatesReported Jun 25, 2025 · 1 year ago
Legal News Analyst ·

Reason for recall

Potential of blood leak occurring between the lower port of the venous chamber and the tubing include: hemodiafiltration (HDF), hemodialysis (HD), hemofiltration (HF), and isolated ultrafiltration.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

5008X HDF Hemodialysis Blood Tubing Set, 24 units per case, with the following models: a. 5008X Standard HDF Bloodline, Model Number: 03-5100-7. b. 5008X Standard HDF Bloodline w/CLIC, Model Number: 03-5100-7C. c. 5008X Standard HDF Bloodline w/ Twister, Model Number: 03-5150-2.

Lot / code information

Model
03-5100-7
UDI
00840861102365 (Bag), 10840861102362 (Case)
Lot #
24LR01214, 24SR01010, 25ER01800. b
Model
03-5100-7C
UDI
0084086110237 (Bag), 10840861102379 (Case)
Lot #
24LR01215, 24SR01011, 25ER01804. c
Model
03-5150-2
UDI
00840861102389 (Bag), 10840861102386 (Case)
Lot #
24LR01216, 24SR01012, 25ER01805

What the firm is doing

Fresenius Medical Care notified its single consignee on 04/29/2025 via telephone call. The consignee was made aware of the issue and affected units and instructed to examine their inventory for those affected units. If they had any affected units, they were instructed to remove them from their inventory immediately and provide contact information to arrange for their return. On 05/14/2025, Fresenius Medical Care expanded the recall to include additional lot numbers and notified consignees. The notification was via telephone call and included the same instructions as the initial letter but included the additional lots. On 06/05/2025, Fresenius Medical Care expanded the recall again to include additional lot numbers and notified consignees. The notification was via telephone call and included the same instructions as the initial letter but included the additional lots. A recall notification letter was sent to the consignee on about 06/23/2025. The letter provided the same information as was verbally communicated in notifications.

DistributionShow details

US Nationwide distribution in the state of Massachusetts.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls